A new approach using a different type of immune cell, however, offers promise in expanding cellular immunotherapy applications to treat more types of cancer, and broader target populations with an ...

Researchers have found that tapping into the body's own immune system and activating a type of immune cell known as B cells, could be the key to boosting the effectiveness of tumor-infiltrating ...

Fate is developing its first-in-class cellular immunotherapy programs through an expanding array of strategic collaborations, and in therapeutic indications where the unmet need is large and where ...

Researchers at Moffitt Cancer Center have found that tapping into the body’s own immune system and activating a type of immune cell could be the key to boosting the effectiveness of tumor-infiltrating ...

A phase 1 clinical trial co-led by researchers at WashU Medicine found that a new type of cell-based immunotherapy was safe for patients with several types of B-cell lymphoma, a type of blood cancer.

Immunotherapy Research: Independently design, plan, and execute experiments involving CAR-T cell engineering, optimization, and evaluation using advanced cellular, molecular, and immunological ...

There are several different kinds of immunotherapies currently used to treat cancer. Two main types are checkpoint inhibitors and cellular immunotherapy. Many cancer immunotherapies rely on the ...

Researchers at Moffitt Cancer Center have found that tapping into the body’s own immune system and activating a type of immune cell known as B cells, could be the key to boosting the effectiveness of ...

An Indian biotech start-up led by a Kashmir scientist has a patented, 3rd-generation CAR-T therapy that targets cancer ...

A phase 1 clinical trial has found one such immunotherapy to be safe for patients with several types of B-cell lymphoma, a type of blood cancer. Larger studies are needed to assess efficacy, but ...